Clinical trials sponsored by Hospital Universitari Vall d'Hebron Research Institute

Phase breakdown

Conditions studied

Recruiting trials led by Hospital Universitari Vall d'Hebron Research Institute

• European Rare Blood Disorders Platform (ENROL)
  NCT06250595 · Phase: Not specified · Ages: Up to 100 Years · Sex: All (male and female) · 1 location
• Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
  NCT07607197 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Integrative Diagnosis for SCD and Other RADs
  NCT07206095 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 9 locations
• Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I
  NCT06503848 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
  NCT06674772 · Phase: Not specified · Ages: 6 Years to 75 Years · Sex: All (male and female) · 1 location
• NOPE37: Angiogenic Factors for Managing Term Preeclampsia
  NCT07193680 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 23 locations
• RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
  NCT06213402 · Phase: Not specified · Ages: 0 Years to 100 Years · Sex: All (male and female) · 1 location
• Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
  NCT07159750 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 26 locations
• Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
  NCT07713537 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke
  NCT05565781 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · 1 location
• Study of the Effects of Time-Restricted Feeding on the Immune Function of Individuals With Obesity
  NCT06858683 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: Female · 1 location
• Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
  NCT06676696 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis
  NCT07168772 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression
  NCT07422519 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 74 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Hospital Universitari Vall d'Hebron Research Institute recruiting for?

Hospital Universitari Vall d'Hebron Research Institute is the lead sponsor of 14 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.